STABILIZATION OF BOTULINUM TOXIN TYPE-A DURING LYOPHILIZATION

被引:30
|
作者
GOODNOUGH, MC
JOHNSON, EA
机构
[1] UNIV WISCONSIN,FOOD RES INST,DEPT FOOD MICROBIOL & TOXICOL,1925 WILLOW DR,MADISON,WI 53706
[2] UNIV WISCONSIN,INST FOOD RES,DEPT BACTERIOL,MADISON,WI 53706
关键词
D O I
10.1128/AEM.58.10.3426-3428.1992
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Botulinum toxin for medical use is diluted to very low concentrations (nanograms per milliliter); when it is preserved by lyophilization, considerable loss of activity can occur. In the present study, conditions that gave >90% recovery of the toxicity after lyophilization of solutions containing 20 to 1,000 mouse 50% lethal doses per ml were found. Toxicity was recovered upon drying 0.1 ml of toxin solution when the pH was maintained below 7 and bovine or human serum albumins were used as stabilizers. Various other substances tested with albumin, including glucose, sucrose, trehalose, mannitol, glycine, and cellibiose, did not increase recovery on drying.
引用
收藏
页码:3426 / 3428
页数:3
相关论文
共 50 条
  • [41] Botulinum toxin type-A therapy in cluster headache: an open study
    Sostak, Petra
    Krause, Phillip
    Foerderreuther, Stefanie
    Reinisch, Veronika
    Straube, Andreas
    JOURNAL OF HEADACHE AND PAIN, 2007, 8 (04): : 236 - 241
  • [42] Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study
    Pauri, F
    Boffa, L
    Cassetta, E
    Pasqualetti, P
    Rossini, PM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 181 (1-2) : 89 - 97
  • [43] PHARMACOLOGICAL STUDIES ON SUBCELLULAR SITE OF ACTION OF BOTULINUM TOXIN TYPE-A
    SIMPSON, LL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1978, 206 (03): : 661 - 669
  • [44] A child with hemicrania continua phenotype responsive to botulinum toxin type-A
    Prasad, Manish
    Ramdas, Sithara
    Abu-Arafeh, Ishaq
    JOURNAL OF PEDIATRIC NEUROLOGY, 2012, 10 (02) : 155 - 159
  • [45] TREATMENT OF ADDUCTOR LARYNGEAL BREATHING DYSTONIA WITH BOTULINUM TOXIN TYPE-A
    GRILLONE, GA
    BLITZER, A
    BRIN, MF
    ANNINO, DJ
    SAINTHILAIRE, MH
    LARYNGOSCOPE, 1994, 104 (01): : 30 - 32
  • [46] Botulinum toxin type-A therapy in cluster headache: an open study
    Petra Sostak
    Phillip Krause
    Stefanie Förderreuther
    Veronika Reinisch
    Andreas Straube
    The Journal of Headache and Pain, 2007, 8 : 236 - 241
  • [47] TREATMENT WITH BOTULINUM TOXIN TYPE-A INJECTION IN CHILDREN WITH CEREBRAL PALSY
    Kuzmina, N.
    Rafikova, Z.
    Yuldashev, I.
    Sakhieva, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 147 - 147
  • [48] THE MEDICAL-MANAGEMENT OF MASSETERIC HYPERTROPHY WITH BOTULINUM TOXIN TYPE-A
    MOORE, AP
    WOOD, GD
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1994, 32 (01): : 26 - 28
  • [49] STUDIES ON THE ORAL TOXICITY OF CLOSTRIDIUM-BOTULINUM TOXIN, TYPE-A
    COLEMAN, IW
    CANADIAN JOURNAL OF BIOCHEMISTRY AND PHYSIOLOGY, 1954, 32 (01): : 27 - 34
  • [50] EVIDENCE THAT SUBUNITS OF TYPE-A BOTULINUM TOXIN NEED NOT BE LINKED BY DISULFIDE
    BHATTACHARYYA, SD
    SUGIYAMA, H
    RUST, P
    LACEY, D
    TOXICON, 1988, 26 (09) : 817 - 825